Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.

AusPAR: Blinatumomab (rch)

Australian Public Assessment Report

AusPAR

AusPAR: Blinatumomab (rch) [PDF, 1.01 MB]

AusPAR: Blinatumomab (rch) [Word, 1.73 MB]

Attachment: Product Information: Blinatumomab (rch) [PDF, 452.75 KB]

Attachment: Product Information: Blinatumomab (rch) [Word, 294.94 KB]

Attachment: Extract from Clinical Evaluation Report: Blinatumomab (rch) [PDF, 2.38 MB]

Attachment: Extract from Clinical Evaluation Report: Blinatumomab (rch) [Word, 5.94 MB]

Device/Product Name

Blincyto

Active ingredients

Blinatumomab (rch)

AusPAR Date

5 February 2018

Published

16 February 2018

Submission Number

PM-2016-01898-1-4

Submission Type

Extension of indications

Decision

Approved